tetano
Editor, Senior Moderator
Eur J Pharmacol
. 2022 Oct 17;175332.
doi: 10.1016/j.ejphar.2022.175332. Online ahead of print.
Anti-inflammatory effects of theaflavin-3'-gallate during influenza virus infection through regulating the TLR4/MAPK/p38 pathway
Mingwei Sima[SUP] 1 [/SUP], Chaoxiang Lv[SUP] 2 [/SUP], Jing Qi[SUP] 3 [/SUP], Jin Guo[SUP] 4 [/SUP], Rongbo Luo[SUP] 2 [/SUP], Xiuwen Deng[SUP] 1 [/SUP], Yuanguo Li[SUP] 2 [/SUP], Tiecheng Wang[SUP] 2 [/SUP], Donghui Yue[SUP] 5 [/SUP], Yuwei Gao[SUP] 6 [/SUP]
Affiliations
Abstract
Severe pathological damage caused by the influenza virus is one of the leading causes of death. However, the prevention and control strategies for influenza virus infection have certain limitations, and the exploration for new influenza antiviral drugs has become the major research direction. This study evaluated the antiviral activities of four theaflavin derivatives (TFs). Cytopathic effect (CPE) reduction assay revealed that theaflavin-3'-gallate (TF2b) and theaflavin (TF1) could effectively inhibit the replication of influenza viruses H1N1-UI182, H1N1-PR8, H3N2, and H5N1, and TF2b exhibited the most significant antiviral activity in vivo. Intraperitoneal injection of TF2b at 40 mg/kg/d effectively alleviated viral pneumonia, maintained body weight, and improved the survival rate of mice infected with a lethal dose of H1N1-UI182 to 55.56%. Hematological analysis of peripheral blood further showed that TF2b increased the number of lymphocytes and decreased the number of neutrophils, monocytes, and platelets in the blood of infected mice. RT-qPCR results showed that TF2b reduced the mRNA expression levels of inflammatory cytokines (IL-6, TNF-α, and IL-1β), chemokines (CXCL-2 and CCL-3), and interferons (IFN-α and IFN-γ) after influenza virus infection. In addition, TF2b significantly down-regulated the expression levels of TLR4, p-p38, p-ERK, and cytokines IL-6, TNF-α, IL-1β, and IL-10. These results suggest that TF2b not only significantly inhibits viral replication and proliferation in vitro, but also alleviates pneumonia injury in vivo. Its antiviral effect might be attributed to the down-regulation of influenza virus-induced inflammatory cytokines by regulating the TLR4/MAPK/p38 signaling pathway.
Keywords: Anti-inflammatory; Influenza a virus; TLR4/MAPK/p38 signaling pathway; Theaflavin derivatives.
. 2022 Oct 17;175332.
doi: 10.1016/j.ejphar.2022.175332. Online ahead of print.
Anti-inflammatory effects of theaflavin-3'-gallate during influenza virus infection through regulating the TLR4/MAPK/p38 pathway
Mingwei Sima[SUP] 1 [/SUP], Chaoxiang Lv[SUP] 2 [/SUP], Jing Qi[SUP] 3 [/SUP], Jin Guo[SUP] 4 [/SUP], Rongbo Luo[SUP] 2 [/SUP], Xiuwen Deng[SUP] 1 [/SUP], Yuanguo Li[SUP] 2 [/SUP], Tiecheng Wang[SUP] 2 [/SUP], Donghui Yue[SUP] 5 [/SUP], Yuwei Gao[SUP] 6 [/SUP]
Affiliations
- PMID: 36265612
- DOI: 10.1016/j.ejphar.2022.175332
Abstract
Severe pathological damage caused by the influenza virus is one of the leading causes of death. However, the prevention and control strategies for influenza virus infection have certain limitations, and the exploration for new influenza antiviral drugs has become the major research direction. This study evaluated the antiviral activities of four theaflavin derivatives (TFs). Cytopathic effect (CPE) reduction assay revealed that theaflavin-3'-gallate (TF2b) and theaflavin (TF1) could effectively inhibit the replication of influenza viruses H1N1-UI182, H1N1-PR8, H3N2, and H5N1, and TF2b exhibited the most significant antiviral activity in vivo. Intraperitoneal injection of TF2b at 40 mg/kg/d effectively alleviated viral pneumonia, maintained body weight, and improved the survival rate of mice infected with a lethal dose of H1N1-UI182 to 55.56%. Hematological analysis of peripheral blood further showed that TF2b increased the number of lymphocytes and decreased the number of neutrophils, monocytes, and platelets in the blood of infected mice. RT-qPCR results showed that TF2b reduced the mRNA expression levels of inflammatory cytokines (IL-6, TNF-α, and IL-1β), chemokines (CXCL-2 and CCL-3), and interferons (IFN-α and IFN-γ) after influenza virus infection. In addition, TF2b significantly down-regulated the expression levels of TLR4, p-p38, p-ERK, and cytokines IL-6, TNF-α, IL-1β, and IL-10. These results suggest that TF2b not only significantly inhibits viral replication and proliferation in vitro, but also alleviates pneumonia injury in vivo. Its antiviral effect might be attributed to the down-regulation of influenza virus-induced inflammatory cytokines by regulating the TLR4/MAPK/p38 signaling pathway.
Keywords: Anti-inflammatory; Influenza a virus; TLR4/MAPK/p38 signaling pathway; Theaflavin derivatives.